Tempus AI (NASDAQ:TEM – Get Free Report) and P3 Health Partners (NASDAQ:PIII – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.
Valuation & Earnings
This table compares Tempus AI and P3 Health Partners”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tempus AI | $1.51 billion | 8.97 | -$245.03 million | ($1.06) | -70.77 |
| P3 Health Partners | $1.50 billion | 0.02 | -$147.95 million | ($33.00) | -0.12 |
P3 Health Partners has lower revenue, but higher earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and price targets for Tempus AI and P3 Health Partners, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tempus AI | 1 | 10 | 11 | 0 | 2.45 |
| P3 Health Partners | 1 | 2 | 1 | 0 | 2.00 |
Tempus AI presently has a consensus price target of $79.37, indicating a potential upside of 5.80%. P3 Health Partners has a consensus price target of $17.00, indicating a potential upside of 321.31%. Given P3 Health Partners’ higher probable upside, analysts plainly believe P3 Health Partners is more favorable than Tempus AI.
Volatility & Risk
Tempus AI has a beta of 3.61, suggesting that its share price is 261% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1.81, suggesting that its share price is 81% more volatile than the S&P 500.
Profitability
This table compares Tempus AI and P3 Health Partners’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tempus AI | -12.54% | -47.00% | -9.44% |
| P3 Health Partners | -6.55% | N/A | -16.40% |
Insider & Institutional Ownership
24.2% of Tempus AI shares are held by institutional investors. Comparatively, 7.7% of P3 Health Partners shares are held by institutional investors. 24.3% of Tempus AI shares are held by insiders. Comparatively, 10.9% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Tempus AI beats P3 Health Partners on 9 of the 14 factors compared between the two stocks.
About Tempus AI
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
About P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
